Can't they just put a lien on the warehouse that was being built and get their money back that way?
Chegerar, what do you make of the late surge in Volume late in the trading day? almost double the 3m avg. There is not much activity on this board, what are your thoughts on the stock? The loss for the quarter was ridiculously huge.
I saw in the last presentation and they explained that they will need cash in order to go on to the next trials. Im guessing they will raise cash through an offering which will most likely cause dilution, so wouldn't it be safe to say we can expect an offering after the presentations???
A reverse split is believed to happen some time in the future. does any one have an idea when they might possibly do one? this is a more general question as to is their a reason for a reverse spit(ex: to help with dilution for a public offering?
The article was written by prop think!!! They did the same bashing article with GALE a few months ago and brought the stock down 60% in one day $1.80-1.23!!! it close at $1.40's and was up to $2 a week later. Everyone saw it was all bull !! and the short probably covered!!!
The company actually took legal action against them!!
"A biotech company claims in court that an investment news website defamed it in articles and made money by shorting the stock.
Galena Biopharma sued PropThink LLC, two of its editors and four "contributors," in Superior Court.
Galena claims the defendants' two articles November articles knocked $39 million off its market cap in a single day
The articles, published on Nov. 12 and 15, "state that Galena, among other things: (a) lacks 'faith' in its own products; (a) [sic] perpetrated a 'hoax' on investors; (c) lacks transparency at the expense of its stockholders; (d) engineered hundreds of millions of dollars of 'phantom' value; and (e) has as its main product candidate something that is not likely to work", according to the 21-page lawsuit."
Google " Galena Propthink lawsuit"" it was the motherload of bashing!!
At the 16 min mark in the conference video the CEO is explaining the trial time periods and the costs. he says the periods are 12 week trial. He then says " if we were to do all three trial, which we wont, the Zertane trial is something we don't plan to do" What does he mean by this are they selling or were was the data not sufficient and they are throwing out the drug?1?
I was thinking the same but then I thought capital gains reasons, and who knows maybe for personal gains. Another thought is that you also need to think these execs didn't buy the stock today they probably have stock at the price of $1-3, which translates into big money at these prices.
In July we were able to ward this off but now its has come around. January 1st of 2013 the lockup will allow for more than two-thirds of the company's shares owned by executives, management and directors to be available for sale. Any thoughts? Dilution?
"Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), reports that Dr. David Bar-Or, Ampio's Founder, Chief Scientific Officer and largest shareholder, and Michael Macaluso, Ampio's CEO, Chairman and Lead Investor, have extended their July 15th 2012 lock-up agreement until January of 2013. This extended lockup encompasses more than two-thirds of the company's shares owned by executives,
management and directors."
So I did some research and was able to find some info on the Aegis Capital Initiation report….
Product Candidate Development Timeline
Ampion: 2012: Pre IND meeting,
2012- 2013: Two phase III trials
2013-2014: Submit BLA
Zertane: 2012: Pre IND meeting,
2012- 2013: Two phase III trials ( till mid 2013)
2013-2014: Submit NDA 505b(2)
Optina: 2012: Pre IND meeting,
2012- 2013: phase II trial (till mid 2013)
2013: Phase III trial (mid year)
2014: Submit NDA 505b(2)
Does any one have an idea of any up coming catalyst? Data release, start of trials, milestones etc.? This company can be frustrating when researching. With no data on clinicaltrials.gov and not even any information on "Bloomberg's Industries Biotech and Pharma Catalyst Calendar" its hard to finf any new information. An are we expecting a lock-up expiration?
Btw this board seems to have lost its activity, at least when there were bashers we had some excitement!
50 Day MA on its way of crossing its 200 Day MA!
As long-term indicators carry more weight, the Golden Cross indicates a bull market on the horizon and is reinforced by high trading volumes. Additionally, the long-term moving average becomes the new support level in the rising market. this cross can be seen as a sign that the market has turned in favor of the stock.
Well I'm just going by the time that it was release on Google Finance and according to that it says that the article was released 9hrs ago, today.
New article that was published 4 hrs ago, on Google Finance but its not coming up on the news feed for Yahoo Finance.
Thanks and best of luck to you too. I wish I had as much but I'm long 1250, although I'm looking to increase my position. I think we have a potential winner here. Someone brought up a great point, we are looking at four potential blockbuster drugs when most biotech's are just counting on one. The markets for these drugs are also well diversified within the industry and have a lot of market share that could be gained if all goes well with positive clinical data and FDA approvals. With the current float and the market cap this stock can squeeze hard due to all the shorts but I do believe that future value (5 yrs) will be in the billions yielding a pps of 50's -80's if not more. Best of Luck to All!!!